- Home
- CTXR vs CARM Comparison
CTXR vs CARM Comparison
Compare CTXR & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- CARM
- Stock Information
- Founded
- CTXR 2007
- CARM 2016
- Country
- CTXR United States
- CARM United States
- Employees
- CTXR N/A
- CARM N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- CTXR Health Care
- CARM Health Care
- Exchange
- CTXR Nasdaq
- CARM Nasdaq
- Market Cap
- CTXR 23.0M
- CARM 12.2M
- IPO Year
- CTXR N/A
- CARM N/A
- Fundamental
- Price
- CTXR $1.33
- CARM $0.22
- Analyst Decision
- CTXR Strong Buy
- CARM Hold
- Analyst Count
- CTXR 3
- CARM 5
- Target Price
- CTXR $53.00
- CARM $0.90
- AVG Volume (30 Days)
- CTXR 443.9K
- CARM 5.0M
- Earning Date
- CTXR 08-12-2025
- CARM 08-07-2025
- Dividend Yield
- CTXR N/A
- CARM N/A
- EPS Growth
- CTXR N/A
- CARM N/A
- EPS
- CTXR N/A
- CARM N/A
- Revenue
- CTXR N/A
- CARM $10,767,000.00
- Revenue This Year
- CTXR N/A
- CARM N/A
- Revenue Next Year
- CTXR $851.67
- CARM N/A
- P/E Ratio
- CTXR N/A
- CARM N/A
- Revenue Growth
- CTXR N/A
- CARM N/A
- 52 Week Low
- CTXR $0.65
- CARM $0.14
- 52 Week High
- CTXR $15.25
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- CTXR 48.91
- CARM 30.81
- Support Level
- CTXR $1.23
- CARM $0.22
- Resistance Level
- CTXR $1.43
- CARM $0.24
- Average True Range (ATR)
- CTXR 0.11
- CARM 0.03
- MACD
- CTXR 0.01
- CARM -0.00
- Stochastic Oscillator
- CTXR 38.46
- CARM 5.15
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.